Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and δ1-opioid receptor agonists is mediated by iNOS

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 5 58-5, 2005, Pages

  Guo, Yiru ^a   Stein, Adam B ^a   Wu, Wen Jian ^a   Zhu, Xiaoping ^a   Tan, Wei ^a   Li, Qianhong ^a   Bolli, Roberto ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Inducible nitric oxide synthase; Myocardial ischemia; Nitric oxide; Reperfusion injury

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; DELTA OPIATE RECEPTOR AGONIST; DIETHYLENETRIAMINE; GLYCERYL TRINITRATE; INDUCIBLE NITRIC OXIDE SYNTHASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; TAN 670; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART RATE; HEART WEIGHT; KNOCKOUT MOUSE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM TEMPERATURE; REPERFUSION INJURY;

ADENOSINE; AMIDINES; ANIMALS; BENZYLAMINES; BLOOD PRESSURE; BODY TEMPERATURE; ENZYME INHIBITORS; HEART RATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; NITRIC OXIDE DONORS; RECEPTOR, ADENOSINE A1; RECEPTORS, OPIOID, DELTA;

EID: 27144459885     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00341.2005     Document Type: Article

References (28)

1. Baxter GF and Ferdinandy P. Delayed preconditioning of myocardium: current perspectives. Basic Res Cardiol 96: 329-344, 2001.
2. Baxter GF, Marber MS, Patel VC, and Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 90: 2993-3000, 1994.
3. 1 receptor triggered) preconditioning: is eNOS masquerading as iNOS? Cardiovasc Res 53: 405-413, 2002.
4. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33: 1897-1918, 2001.
5. Bolli R. The late phase of preconditioning. Circ Res 87: 972-983, 2000.
6. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, and Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93: 325-338, 1998.
7. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, and Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278: H643-H651, 2000.
8. Csonka C, Varga E, Kovacs P, Ferdinandy P, Blasig IE, Szilvassy Z, and Tosaki A. Heme oxygenase and cardiac function in ischemic/reperfused rat hearts. Free Radic Biol Med 27: 119-126, 1999.
9. Elliott GT, Sowell CG, Walker EB, Weber PA, Moore J, and Gross GJ. The novel glycolipid RC-552 attenuates myocardial stunning and reduces infarct size in dogs. J Mol Cell Cardiol 32: 1327-1339, 2000.
10. Gross GJ. Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 35: 709-718, 2003.
11. Guo Y, Bao W, Wu WJ, Shinmura K, Tang XL, and Bolli R. Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice. Basic Res Cardiol 95: 479-484, 2000.
12. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y, and Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 96: 11507-11512, 1999.
13. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, and Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 275: H1375-H1387, 1998.
14. Guo Y, Xuan YT, Wu WJ, Li Q, Tang XL, and Bolli R. Nitric oxide plays a dual role in exercise-induced late preconditioning (Abstract). Circulation 104, Suppl II, 60, 2001.
15. Heusch G. Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug? Circulation 103: 2876-2878, 2001.
16. Jiang X, Shi E, Nakajima Y, and Sato S. Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice. Anesthesiology 101: 82-88, 2004.
17. Laubach VE, Shesely EG, Smithies O, and Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92: 10688-10692, 1995.
18. Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, and Bolli R. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 103: 2935-2941, 2001.
19. Qiu Y, Rizvi A, Tang XL, Manchikalapudi S, Takano H, Jadoon AK, Wu WJ, and Bolli R. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol Heart Circ Physiol 273: H2931-H2936, 1997.
20. Shinmura K, Bolli R, Liu SQ, Tang XL, Kodani E, Xuan YT, Srivastava S, and Bhatnagar A. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res 91: 240-246, 2002.
21. Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A, and Bolli R. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 97: 10197-10202, 2000.
22. 3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 88: 520-528, 2001.
23. Takano H, Tang XL, Qiu Y, Guo Y, French BA, and Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res 83: 73-84, 1998.
24. Wang G, Liem DA, Vondriska TM, Honda HM, Korge P, Pantaleon DM, Qiao X, Wang Y, Weiss JN, and Ping P. Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 288: H1290-H1295, 2005.
25. Xi L, Salloum F, Tekin D, Jarrett NC, and Kukreja RC. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice. Am J Physiol Heart Circ Physiol 277: H2418-H2424, 1999.
26. Zhao L, Weber PA, Smith JR, Comerford ML, and Elliott GT. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A. J Mol Cell Cardiol 29: 1567-1576, 1997.
27. 1 receptors: evidence from gene-knockout mice. Circulation 102: 902-907, 2000.
28. ATP channels. Am J Physiol Heart Circ Physiol 280: H1278-H1285, 2001.